|
Longeveron Inc. (LGVN) DCF -Bewertung
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Longeveron Inc. (LGVN) Bundle
Verbessern Sie Ihre Anlagestrategien mit dem (LGVN) DCF -Taschenrechner! Erforschen Sie die Finanzdaten von Genuine Longeveron Inc., passen Sie Wachstumsprojektionen und -kosten an und beobachten Sie sofort, wie diese Modifikationen den inneren Wert von (LGVN) beeinflussen.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.6 | 1.3 | 1.2 | .7 | 2.4 | 2.2 | 2.1 | 2.0 | 1.8 | 1.7 |
| Revenue Growth, % | 0 | -76.8 | -6.43 | -41.98 | 237.38 | -6.3 | -6.3 | -6.3 | -6.3 | -6.3 |
| EBITDA | -2.9 | -16.2 | -17.2 | -20.1 | -16.5 | -2.0 | -1.9 | -1.8 | -1.7 | -1.6 |
| EBITDA, % | -52.03 | -1239.28 | -1403.44 | -2829.34 | -690.72 | -90.41 | -90.41 | -90.41 | -90.41 | -90.41 |
| Depreciation | .8 | .9 | .9 | .9 | .0 | 1.2 | 1.1 | 1.0 | .9 | .9 |
| Depreciation, % | 13.95 | 69.98 | 73.08 | 133.43 | 0 | 51.4 | 51.4 | 51.4 | 51.4 | 51.4 |
| EBIT | -3.7 | -17.1 | -18.0 | -21.0 | -16.5 | -2.1 | -2.0 | -1.8 | -1.7 | -1.6 |
| EBIT, % | -65.98 | -1309.26 | -1476.51 | -2962.76 | -690.72 | -93.2 | -93.2 | -93.2 | -93.2 | -93.2 |
| Total Cash | .8 | 35.0 | 19.7 | 5.4 | 19.2 | 1.9 | 1.7 | 1.6 | 1.5 | 1.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .4 | .1 | .2 | .1 | .1 | .2 | .2 | .2 | .2 | .2 |
| Account Receivables, % | 7.47 | 4.21 | 17.84 | 15.66 | 3.51 | 9.74 | 9.74 | 9.74 | 9.74 | 9.74 |
| Inventories | .0 | .0 | -.6 | .0 | .0 | -.2 | -.2 | -.2 | -.2 | -.2 |
| Inventories, % | 0 | 0 | -50.9 | 0 | 0 | -10.18 | -10.18 | -10.18 | -10.18 | -10.18 |
| Accounts Payable | 1.6 | .6 | 1.8 | .6 | .1 | 1.2 | 1.1 | 1.1 | 1.0 | .9 |
| Accounts Payable, % | 28.24 | 49.39 | 143.29 | 89.99 | 4.14 | 54.35 | 54.35 | 54.35 | 54.35 | 54.35 |
| Capital Expenditure | -.3 | -1.3 | -.9 | -.7 | .0 | -1.2 | -1.1 | -1.1 | -1.0 | -.9 |
| Capital Expenditure, % | -4.65 | -100.31 | -70.05 | -97.88 | 0 | -54.52 | -54.52 | -54.52 | -54.52 | -54.52 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -3.8 | -17.2 | -18.8 | -21.0 | -16.5 | -2.1 | -2.0 | -1.8 | -1.7 | -1.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -2.1 | -18.2 | -17.2 | -22.4 | -17.0 | -.9 | -2.1 | -2.0 | -1.8 | -1.7 |
| WACC, % | 5.65 | 5.65 | 5.65 | 5.65 | 5.65 | 5.65 | 5.65 | 5.65 | 5.65 | 5.65 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -7.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -2 | |||||||||
| Terminal Value | -48 | |||||||||
| Present Terminal Value | -37 | |||||||||
| Enterprise Value | -44 | |||||||||
| Net Debt | -18 | |||||||||
| Equity Value | -26 | |||||||||
| Diluted Shares Outstanding, MM | 94 | |||||||||
| Equity Value Per Share | -0.28 |
What You Will Get
- Comprehensive LGVN Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed automatically.
- Scenario Analysis: Explore various scenarios to assess Longeveron Inc.'s future performance.
- User-Friendly Design: Designed for professionals while remaining easy to navigate for newcomers.
Key Features
- Real-Life LGVN Data: Pre-filled with Longeveron Inc.'s historical financials and future projections.
- Fully Customizable Inputs: Modify revenue growth, profit margins, WACC, tax rates, and capital expenditures to suit your analysis.
- Dynamic Valuation Model: Automatically updates Net Present Value (NPV) and intrinsic value based on your customized inputs.
- Scenario Testing: Develop multiple forecasting scenarios to evaluate various valuation results.
- User-Friendly Design: Intuitive, organized, and tailored for both professionals and newcomers.
How It Works
- Step 1: Download the prebuilt Excel template featuring Longeveron Inc.'s (LGVN) data.
- Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see recalculated results, including Longeveron Inc.'s (LGVN) intrinsic value.
- Step 5: Use the outputs to make informed investment decisions or create reports.
Why Choose This Calculator for Longeveron Inc. (LGVN)?
- User-Friendly Interface: Tailored for both novices and seasoned professionals.
- Customizable Inputs: Adjust parameters easily to suit your financial analysis.
- Real-Time Valuation: Instantly view changes in Longeveron’s valuation as you modify inputs.
- Preloaded Data: Comes with Longeveron’s actual financial metrics for swift evaluations.
- Relied Upon by Experts: Favored by investors and analysts for making strategic decisions.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive valuation models for assessing Longeveron Inc. (LGVN) investments.
- Biotech Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the company.
- Consultants and Advisors: Deliver precise valuation insights for clients interested in Longeveron Inc. (LGVN).
- Students and Educators: Utilize current data to practice and teach financial modeling in the biotech sector.
- Biotech Enthusiasts: Gain insights into the valuation processes of innovative companies like Longeveron Inc. (LGVN).
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Longeveron Inc. (LGVN) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Longeveron Inc. (LGVN).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.